1. Home
  2. ANAB vs ALM Comparison

ANAB vs ALM Comparison

Compare ANAB & ALM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANAB
  • ALM
  • Stock Information
  • Founded
  • ANAB 2005
  • ALM N/A
  • Country
  • ANAB United States
  • ALM Canada
  • Employees
  • ANAB N/A
  • ALM N/A
  • Industry
  • ANAB Biotechnology: Pharmaceutical Preparations
  • ALM Other Metals and Minerals
  • Sector
  • ANAB Health Care
  • ALM Basic Materials
  • Exchange
  • ANAB Nasdaq
  • ALM Nasdaq
  • Market Cap
  • ANAB 951.1M
  • ALM 958.4M
  • IPO Year
  • ANAB 2017
  • ALM N/A
  • Fundamental
  • Price
  • ANAB $36.12
  • ALM $7.09
  • Analyst Decision
  • ANAB Buy
  • ALM Strong Buy
  • Analyst Count
  • ANAB 12
  • ALM 2
  • Target Price
  • ANAB $59.30
  • ALM $11.50
  • AVG Volume (30 Days)
  • ANAB 365.9K
  • ALM 3.9M
  • Earning Date
  • ANAB 10-31-2025
  • ALM 11-20-2025
  • Dividend Yield
  • ANAB N/A
  • ALM N/A
  • EPS Growth
  • ANAB N/A
  • ALM N/A
  • EPS
  • ANAB N/A
  • ALM N/A
  • Revenue
  • ANAB $123,164,000.00
  • ALM $20,657,545.00
  • Revenue This Year
  • ANAB $24.36
  • ALM $121.93
  • Revenue Next Year
  • ANAB N/A
  • ALM $133.39
  • P/E Ratio
  • ANAB N/A
  • ALM N/A
  • Revenue Growth
  • ANAB 304.17
  • ALM 9.87
  • 52 Week Low
  • ANAB $12.21
  • ALM $3.16
  • 52 Week High
  • ANAB $38.39
  • ALM $10.68
  • Technical
  • Relative Strength Index (RSI)
  • ANAB 72.97
  • ALM 49.38
  • Support Level
  • ANAB $33.01
  • ALM $6.17
  • Resistance Level
  • ANAB $35.58
  • ALM $9.06
  • Average True Range (ATR)
  • ANAB 1.67
  • ALM 0.93
  • MACD
  • ANAB -0.05
  • ALM -0.28
  • Stochastic Oscillator
  • ANAB 68.61
  • ALM 20.32

About ANAB AnaptysBio Inc.

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

About ALM Almonty Industries Inc. Common Shares

Almonty Industries Inc is engaged in the mining, processing, and shipping of tungsten concentrate from its Los Santos tungsten mine located near Salamanca, Spain - the Los Santos Mine, the processing and shipping of tungsten concentrate from its Panasqueira tin and tungsten mine in Covilha, Castelo Branco, Portugal - the Panasqueira Mine, the evaluation of its Valtreixal tin and tungsten mine project located in Western Spain in the province of Zamora - the Valtreixal Mine, as well as the exploration and evaluation of its Sangdong tungsten mine project located in Gangwon Province, Republic of Korea - the Sangdong Mine.

Share on Social Networks: